NGL Fine Chem Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.20 | 0.14 | 0.14 | 0.13 | 0.17 |
Long Term Debt-Equity Ratio | 0.05 | 0.01 | 0.01 | 0.03 | 0.06 |
Current Ratio | 1.58 | 1.87 | 2.11 | 2.21 | 1.94 |
Fixed Assets | 2.52 | 3.15 | 2.86 | 3.60 | 3.11 |
Inventory | 7.84 | 9.46 | 6.70 | 6.86 | 7.85 |
Debtors | 4.41 | 4.44 | 4.23 | 6.22 | 8.10 |
Interest Cover Ratio | 8.51 | 29.17 | 15.54 | 37.12 | 35.55 |
PBIDTM (%) | 10.11 | 18.44 | 13.21 | 24.65 | 33.15 |
PBITM (%) | 7.53 | 15.96 | 10.34 | 22.25 | 30.29 |
PBDTM (%) | 9.23 | 17.89 | 12.54 | 24.05 | 32.30 |
CPM (%) | 7.63 | 14.19 | 10.19 | 18.80 | 24.35 |
APATM (%) | 5.05 | 11.71 | 7.32 | 16.40 | 21.49 |
ROCE (%) | 8.20 | 18.73 | 11.37 | 34.27 | 51.07 |
RONW (%) | 6.68 | 15.78 | 9.31 | 28.87 | 43.22 |